1 Market Overview 1.1 Biologics and Biosimilars Introduction 1.2 Market Analysis by Type 1.2.1 Overview: Global Biologics and Biosimilars Revenue by Type: 2015 VS 2019 VS 2025 1.2.2 Monoclonal Antibodies 1.2.3 Interferon 1.2.4 Erythropoietin 1.2.5 Insulin 1.2.6 Vaccines 1.2.7 Other 1.3 Market Analysis by Application 1.3.1 Overview: Global Biologics and Biosimilars Revenue by Application: 2015 VS 2019 VS 2025 1.3.2 Tumor 1.3.3 Diabetes 1.3.4 Cardiovascular 1.3.5 Hemophilia 1.3.6 Other 1.4 Overview of Global Biologics and Biosimilars Market 1.4.1 Global Biologics and Biosimilars Market Status and Outlook (2015-2025) 1.4.2 North America (United States, Canada and Mexico) 1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy) 1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.5 South America, Middle East & Africa 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 1.6 COVID-19 Outbreak: Biologics and Biosimilars Industry Impact 1.6.1 COVID-19 Potential Implications for the Biologics and Biosimilars 1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Biologics and Biosimilars 1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April 1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4 1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2 1.6.2 Opportunity Analysis in Covid-19 Crisis 1.6.3 Market Risk and Restraints 1.6.4 Market Driving Force 2 Manufacturers Profiles 2.1 Roche 2.1.1 Roche Details 2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis 2.1.3 Roche SWOT Analysis 2.1.4 Roche Product and Services 2.1.5 Roche Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.2 Eli Lilly 2.2.1 Eli Lilly Details 2.2.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis 2.2.3 Eli Lilly SWOT Analysis 2.2.4 Eli Lilly Product and Services 2.2.5 Eli Lilly Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.3 Sanofi-Aventis 2.3.1 Sanofi-Aventis Details 2.3.2 Sanofi-Aventis Major Business and Total Revenue (Financial Highlights) Analysis 2.3.3 Sanofi-Aventis SWOT Analysis 2.3.4 Sanofi-Aventis Product and Services 2.3.5 Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.4 Amgen 2.4.1 Amgen Details 2.4.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis 2.4.3 Amgen SWOT Analysis 2.4.4 Amgen Product and Services 2.4.5 Amgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.5 Novo Nordisk 2.5.1 Novo Nordisk Details 2.5.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis 2.5.3 Novo Nordisk SWOT Analysis 2.5.4 Novo Nordisk Product and Services 2.5.5 Novo Nordisk Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.6 AbbVie 2.6.1 AbbVie Details 2.6.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis 2.6.3 AbbVie SWOT Analysis 2.6.4 AbbVie Product and Services 2.6.5 AbbVie Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.7 Merck 2.7.1 Merck Details 2.7.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis 2.7.3 Merck SWOT Analysis 2.7.4 Merck Product and Services 2.7.5 Merck Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.8 Pfizer 2.8.1 Pfizer Details 2.8.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis 2.8.3 Pfizer SWOT Analysis 2.8.4 Pfizer Product and Services 2.8.5 Pfizer Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.9 Johnson & Johnson 2.9.1 Johnson & Johnson Details 2.9.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis 2.9.3 Johnson & Johnson SWOT Analysis 2.9.4 Johnson & Johnson Product and Services 2.9.5 Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.10 Novartis 2.10.1 Novartis Details 2.10.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis 2.10.3 Novartis SWOT Analysis 2.10.4 Novartis Product and Services 2.10.5 Novartis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.11 Gelgen 2.11.1 Gelgen Details 2.11.2 Gelgen Major Business and Total Revenue (Financial Highlights) Analysis 2.11.3 Gelgen SWOT Analysis 2.11.4 Gelgen Product and Services 2.11.5 Gelgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.12 Ganlee 2.12.1 Ganlee Details 2.12.2 Ganlee Major Business and Total Revenue (Financial Highlights) Analysis 2.12.3 Ganlee SWOT Analysis 2.12.4 Ganlee Product and Services 2.12.5 Ganlee Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.13 3sbio 2.13.1 3sbio Details 2.13.2 3sbio Major Business and Total Revenue (Financial Highlights) Analysis 2.13.3 3sbio SWOT Analysis 2.13.4 3sbio Product and Services 2.13.5 3sbio Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.14 Innovent 2.14.1 Innovent Details 2.14.2 Innovent Major Business and Total Revenue (Financial Highlights) Analysis 2.14.3 Innovent SWOT Analysis 2.14.4 Innovent Product and Services 2.14.5 Innovent Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.15 Biotech 2.15.1 Biotech Details 2.15.2 Biotech Major Business and Total Revenue (Financial Highlights) Analysis 2.15.3 Biotech SWOT Analysis 2.15.4 Biotech Product and Services 2.15.5 Biotech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.16 Changchun High Tech 2.16.1 Changchun High Tech Details 2.16.2 Changchun High Tech Major Business and Total Revenue (Financial Highlights) Analysis 2.16.3 Changchun High Tech SWOT Analysis 2.16.4 Changchun High Tech Product and Services 2.16.5 Changchun High Tech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.17 Dong Bao 2.17.1 Dong Bao Details 2.17.2 Dong Bao Major Business and Total Revenue (Financial Highlights) Analysis 2.17.3 Dong Bao SWOT Analysis 2.17.4 Dong Bao Product and Services 2.17.5 Dong Bao Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.18 CP Guojian 2.18.1 CP Guojian Details 2.18.2 CP Guojian Major Business and Total Revenue (Financial Highlights) Analysis 2.18.3 CP Guojian SWOT Analysis 2.18.4 CP Guojian Product and Services 2.18.5 CP Guojian Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 3 Sales, Revenue and Market Share by Manufacturer 3.1 Global Biologics and Biosimilars Sales and Market Share by Manufacturer (2018-2019) 3.2 Global Biologics and Biosimilars Revenue and Market Share by Manufacturer (2018-2019) 3.3 Market Concentration Rate 3.3.1 Top 3 Biologics and Biosimilars Manufacturer Market Share in 2019 3.3.2 Top 6 Biologics and Biosimilars Manufacturer Market Share in 2019 3.4 Market Competition Trend 4 Global Market Analysis by Regions 4.1 Global Biologics and Biosimilars Sales, Revenue and Market Share by Regions 4.1.1 Global Biologics and Biosimilars Sales and Market Share by Regions (2015-2020) 4.1.2 Global Biologics and Biosimilars Revenue and Market Share by Regions (2015-2020) 4.2 North America Biologics and Biosimilars Sales and Growth Rate (2015-2020) 4.3 Europe Biologics and Biosimilars Sales and Growth Rate (2015-2020) 4.4 Asia-Pacific Biologics and Biosimilars Sales and Growth Rate (2015-2020) 4.5 South America Biologics and Biosimilars Sales and Growth Rate (2015-2020) 4.6 Middle East and Africa Biologics and Biosimilars Sales and Growth Rate (2015-2020) 5 North America by Country 5.1 North America Biologics and Biosimilars Sales, Revenue and Market Share by Country 5.1.1 North America Biologics and Biosimilars Sales and Market Share by Country (2015-2020) 5.1.2 North America Biologics and Biosimilars Revenue and Market Share by Country (2015-2020) 5.2 United States Biologics and Biosimilars Sales and Growth Rate (2015-2020) 5.3 Canada Biologics and Biosimilars Sales and Growth Rate (2015-2020) 5.4 Mexico Biologics and Biosimilars Sales and Growth Rate (2015-2020) 6 Europe by Country 6.1 Europe Biologics and Biosimilars Sales, Revenue and Market Share by Country 6.1.1 Europe Biologics and Biosimilars Sales and Market Share by Country (2015-2020) 6.1.2 Europe Biologics and Biosimilars Revenue and Market Share by Country (2015-2020) 6.2 Germany Biologics and Biosimilars Sales and Growth Rate (2015-2020) 6.3 UK Biologics and Biosimilars Sales and Growth Rate (2015-2020) 6.4 France Biologics and Biosimilars Sales and Growth Rate (2015-2020) 6.5 Russia Biologics and Biosimilars Sales and Growth Rate (2015-2020) 6.6 Italy Biologics and Biosimilars Sales and Growth Rate (2015-2020) 7 Asia-Pacific by Regions 7.1 Asia-Pacific Biologics and Biosimilars Sales, Revenue and Market Share by Regions 7.1.1 Asia-Pacific Biologics and Biosimilars Sales and Market Share by Regions (2015-2020) 7.1.2 Asia-Pacific Biologics and Biosimilars Revenue and Market Share by Regions (2015-2020) 7.2 China Biologics and Biosimilars Sales and Growth Rate (2015-2020) 7.3 Japan Biologics and Biosimilars Sales and Growth Rate (2015-2020) 7.4 Korea Biologics and Biosimilars Sales and Growth Rate (2015-2020) 7.5 India Biologics and Biosimilars Sales and Growth Rate (2015-2020) 7.6 Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2015-2020) 7.7 Australia Biologics and Biosimilars Sales and Growth Rate (2015-2020) 8 South America by Country 8.1 South America Biologics and Biosimilars Sales, Revenue and Market Share by Country 8.1.1 South America Biologics and Biosimilars Sales and Market Share by Country (2015-2020) 8.1.2 South America Biologics and Biosimilars Revenue and Market Share by Country (2015-2020) 8.2 Brazil Biologics and Biosimilars Sales and Growth Rate (2015-2020) 8.3 Argentina Biologics and Biosimilars Sales and Growth Rate (2015-2020) 9 Middle East & Africa by Countries 9.1 Middle East & Africa Biologics and Biosimilars Sales, Revenue and Market Share by Country 9.1.1 Middle East & Africa Biologics and Biosimilars Sales and Market Share by Country (2015-2020) 9.1.2 Middle East & Africa Biologics and Biosimilars Revenue and Market Share by Country (2015-2020) 9.2 Saudi Arabia Biologics and Biosimilars Sales and Growth Rate (2015-2020) 9.3 Turkey Biologics and Biosimilars Sales and Growth Rate (2015-2020) 9.4 Egypt Biologics and Biosimilars Sales and Growth Rate (2015-2020) 9.5 South Africa Biologics and Biosimilars Sales and Growth Rate (2015-2020) 10 Market Segment by Type 10.1 Global Biologics and Biosimilars Sales and Market Share by Type (2015-2020) 10.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2015-2020) 10.3 Global Biologics and Biosimilars Price by Type (2015-2020) 11 Global Biologics and Biosimilars Market Segment by Application 11.1 Global Biologics and Biosimilars Sales Market Share by Application (2015-2020) 11.2 Global Biologics and Biosimilars Revenue Market Share by Application (2015-2020) 11.3 Global Biologics and Biosimilars Price by Application (2015-2020) 12 Market Forecast 12.1 Global Biologics and Biosimilars Sales, Revenue and Growth Rate (2021-2025) 12.2 Biologics and Biosimilars Market Forecast by Regions (2021-2025) 12.2.1 North America Biologics and Biosimilars Market Forecast (2021-2025) 12.2.2 Europe Biologics and Biosimilars Market Forecast (2021-2025) 12.2.3 Asia-Pacific Biologics and Biosimilars Market Forecast (2021-2025) 12.2.4 South America Biologics and Biosimilars Market Forecast (2021-2025) 12.2.5 Middle East & Africa Biologics and Biosimilars Market Forecast (2021-2025) 12.3 Biologics and Biosimilars Market Forecast by Type (2021-2025) 12.3.1 Global Biologics and Biosimilars Sales Forecast by Type (2021-2025) 12.3.2 Global Biologics and Biosimilars Market Share Forecast by Type (2021-2025) 12.4 Biologics and Biosimilars Market Forecast by Application (2021-2025) 12.4.1 Global Biologics and Biosimilars Sales Forecast by Application (2021-2025) 12.4.2 Global Biologics and Biosimilars Market Share Forecast by Application (2021-2025) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source 15.3 Disclaimer 15.4 About US

List of Tables Table 1. Global Biologics and Biosimilars Revenue (USD Million) by Type: 2015 VS 2019 VS 2025 Table 2. Breakdown of Biologics and Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3) Table 3. Global Biologics and Biosimilars Market Size and Growth Estimation in Various Scenarios in 2020 Table 4. Global Biologics and Biosimilars Revenue (USD Million) by Application: 2015 VS 2019 VS 2025 Table 5. Market Opportunities in Next Few Years Table 6. Market Risks Analysis Table 7. Market Drivers Table 8. Roche Basic Information, Manufacturing Base and Competitors Table 9. Roche Biologics and Biosimilars Major Business Table 10. Roche Biologics and Biosimilars Total Revenue (USD Million) (2018-2019) Table 11. Roche SWOT Analysis Table 12. Roche Biologics and Biosimilars Product and Services Table 13. Roche Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 14. Eli Lilly Basic Information, Manufacturing Base and Competitors Table 15. Eli Lilly Biologics and Biosimilars Major Business Table 16. Eli Lilly Biologics and Biosimilars Total Revenue (USD Million) (2018-2019) Table 17. Eli Lilly SWOT Analysis Table 18. Eli Lilly Biologics and Biosimilars Product and Services Table 19. Eli Lilly Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 20. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors Table 21. Sanofi-Aventis Biologics and Biosimilars Major Business Table 22. Sanofi-Aventis Biologics and Biosimilars Total Revenue (USD Million) (2018-2019) Table 23. Sanofi-Aventis SWOT Analysis Table 24. Sanofi-Aventis Biologics and Biosimilars Product and Services Table 25. Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 26. Amgen Basic Information, Manufacturing Base and Competitors Table 27. Amgen Biologics and Biosimilars Major Business Table 28. Amgen Biologics and Biosimilars Total Revenue (USD Million) (2018-2019) Table 29. Amgen SWOT Analysis Table 30. Amgen Biologics and Biosimilars Product and Services Table 31. Amgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 32. Novo Nordisk Basic Information, Manufacturing Base and Competitors Table 33. Novo Nordisk Biologics and Biosimilars Major Business Table 34. Novo Nordisk Biologics and Biosimilars Total Revenue (USD Million) (2018-2019) Table 35. Novo Nordisk SWOT Analysis Table 36. Novo Nordisk Biologics and Biosimilars Product and Services Table 37. Novo Nordisk Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 38. AbbVie Basic Information, Manufacturing Base and Competitors Table 39. AbbVie Biologics and Biosimilars Major Business Table 40. AbbVie Biologics and Biosimilars Total Revenue (USD Million) (2018-2019) Table 41. AbbVie SWOT Analysis Table 42. AbbVie Biologics and Biosimilars Product and Services Table 43. AbbVie Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 44. Merck Basic Information, Manufacturing Base and Competitors Table 45. Merck Biologics and Biosimilars Major Business Table 46. Merck Biologics and Biosimilars Total Revenue (USD Million) (2018-2019) Table 47. Merck SWOT Analysis Table 48. Merck Biologics and Biosimilars Product and Services Table 49. Merck Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 50. Pfizer Basic Information, Manufacturing Base and Competitors Table 51. Pfizer Biologics and Biosimilars Major Business Table 52. Pfizer Biologics and Biosimilars Total Revenue (USD Million) (2018-2019) Table 53. Pfizer SWOT Analysis Table 54. Pfizer Biologics and Biosimilars Product and Services Table 55. Pfizer Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 56. Johnson & Johnson Basic Information, Manufacturing Base and Competitors Table 57. Johnson & Johnson Biologics and Biosimilars Major Business Table 58. Johnson & Johnson Biologics and Biosimilars Total Revenue (USD Million) (2018-2019) Table 59. Johnson & Johnson SWOT Analysis Table 60. Johnson & Johnson Biologics and Biosimilars Product and Services Table 61. Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 62. Novartis Basic Information, Manufacturing Base and Competitors Table 63. Novartis Biologics and Biosimilars Major Business Table 64. Novartis Biologics and Biosimilars Total Revenue (USD Million) (2018-2019) Table 65. Novartis SWOT Analysis Table 66. Novartis Biologics and Biosimilars Product and Services Table 67. Novartis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 68. Gelgen Basic Information, Manufacturing Base and Competitors Table 69. Gelgen Biologics and Biosimilars Major Business Table 70. Gelgen Biologics and Biosimilars Total Revenue (USD Million) (2018-2019) Table 71. Gelgen SWOT Analysis Table 72. Gelgen Biologics and Biosimilars Product and Services Table 73. Gelgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 74. Ganlee Basic Information, Manufacturing Base and Competitors Table 75. Ganlee Biologics and Biosimilars Major Business Table 76. Ganlee Biologics and Biosimilars Total Revenue (USD Million) (2018-2019) Table 77. Ganlee SWOT Analysis Table 78. Ganlee Biologics and Biosimilars Product and Services Table 79. Ganlee Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 80. 3sbio Basic Information, Manufacturing Base and Competitors Table 81. 3sbio Biologics and Biosimilars Major Business Table 82. 3sbio Biologics and Biosimilars Total Revenue (USD Million) (2018-2019) Table 83. 3sbio SWOT Analysis Table 84. 3sbio Biologics and Biosimilars Product and Services Table 85. 3sbio Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 86. Innovent Basic Information, Manufacturing Base and Competitors Table 87. Innovent Biologics and Biosimilars Major Business Table 88. Innovent Biologics and Biosimilars Total Revenue (USD Million) (2018-2019) Table 89. Innovent SWOT Analysis Table 90. Innovent Biologics and Biosimilars Product and Services Table 91. Innovent Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 92. Biotech Basic Information, Manufacturing Base and Competitors Table 93. Biotech Biologics and Biosimilars Major Business Table 94. Biotech Biologics and Biosimilars Total Revenue (USD Million) (2018-2019) Table 95. Biotech SWOT Analysis Table 96. Biotech Biologics and Biosimilars Product and Services Table 97. Biotech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 98. Changchun High Tech Basic Information, Manufacturing Base and Competitors Table 99. Changchun High Tech Biologics and Biosimilars Major Business Table 100. Changchun High Tech Biologics and Biosimilars Total Revenue (USD Million) (2018-2019) Table 101. Changchun High Tech SWOT Analysis Table 102. Changchun High Tech Biologics and Biosimilars Product and Services Table 103. Changchun High Tech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 104. Dong Bao Basic Information, Manufacturing Base and Competitors Table 105. Dong Bao Biologics and Biosimilars Major Business Table 106. Dong Bao Biologics and Biosimilars Total Revenue (USD Million) (2018-2019) Table 107. Dong Bao SWOT Analysis Table 108. Dong Bao Biologics and Biosimilars Product and Services Table 109. Dong Bao Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 110. CP Guojian Biologics and Biosimilars Type and Application Table 111. CP Guojian Biologics and Biosimilars Major Business Table 112. CP Guojian Biologics and Biosimilars Total Revenue (USD Million) (2018-2019) Table 113. CP Guojian SWOT Analysis Table 114. CP Guojian Biologics and Biosimilars Product and Services Table 115. CP Guojian Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 116. Global Biologics and Biosimilars Sales by Manufacturer (2018-2019) (K Units) Table 117. Global Biologics and Biosimilars Revenue by Manufacturer (2018-2019) (USD Million) Table 118. Global Biologics and Biosimilars Sales by Regions (2015-2020) (K Units) Table 119. Global Biologics and Biosimilars Sales Market Share by Regions (2015-2020) Table 120. Global Biologics and Biosimilars Revenue by Regions (2015-2020) (USD Million) Table 121. North America Biologics and Biosimilars Sales by Countries (2015-2020) (K Units) Table 122. North America Biologics and Biosimilars Sales Market Share by Countries (2015-2020) Table 123. North America Biologics and Biosimilars Revenue by Countries (2015-2020) (USD Million) Table 124. North America Biologics and Biosimilars Revenue Market Share by Countries (2015-2020) Table 125. Europe Biologics and Biosimilars Sales by Countries (2015-2020) (K Units) Table 126. Europe Biologics and Biosimilars Sales Market Share by Countries (2015-2020) Table 127. Europe Biologics and Biosimilars Revenue by Countries (2015-2020) (USD Million) Table 128. Asia-Pacific Biologics and Biosimilars Sales by Regions (2015-2020) (K Units) Table 129. Asia-Pacific Biologics and Biosimilars Sales Market Share by Regions (2015-2020) Table 130. Asia-Pacific Biologics and Biosimilars Revenue by Regions (2015-2020) (USD Million) Table 131. South America Biologics and Biosimilars Sales by Countries (2015-2020) (K Units) Table 132. South America Biologics and Biosimilars Sales Market Share by Countries (2015-2020) Table 133. South America Biologics and Biosimilars Revenue by Countries (2015-2020) (USD Million) Table 134. South America Biologics and Biosimilars Revenue Market Share by Countries (2015-2020) Table 135. Middle East & Africa Biologics and Biosimilars Sales by Countries (2015-2020) (K Units) Table 136. Middle East & Africa Biologics and Biosimilars Sales Market Share by Countries (2015-2020) Table 137. Middle East & Africa Biologics and Biosimilars Revenue by Countries (2015-2020) (USD Million) Table 138. Middle East & Africa Biologics and Biosimilars Revenue Market Share by Countries (2015-2020) Table 139. Global Biologics and Biosimilars Sales by Type (2015-2020) (K Units) Table 140. Global Biologics and Biosimilars Sales Share by Type (2015-2020) Table 141. Global Biologics and Biosimilars Revenue by Type (2015-2020) (USD Million) Table 142. Global Biologics and Biosimilars Revenue Share by Type (2015-2020) Table 143. Global Biologics and Biosimilars Sales by Application (2015-2020) (K Units) Table 144. Global Biologics and Biosimilars Sales Share by Application (2015-2020) Table 145. Global Biologics and Biosimilars Sales Forecast by Regions (2021-2025) (K Units) Table 146. Global Biologics and Biosimilars Market Share Forecast by Regions (2021-2025) Table 147. Global Biologics and Biosimilars Sales Forecast by Type (2021-2025) (K Units) Table 148. Global Biologics and Biosimilars Market Share Forecast by Type (2021-2025) Table 149. Global Biologics and Biosimilars Sales Forecast by Application (2021-2025) Table 150. Global Biologics and Biosimilars Market Share Forecast by Application (2021-2025) Table 151. Direct Channel Pros & Cons Table 152. Indirect Channel Pros & Cons Table 153. Distributors/Traders/ Dealers List List of Figures Figure 1. Biologics and Biosimilars Picture Figure 2. Global Sales Market Share of Biologics and Biosimilars by Type in 2019 Figure 3. Monoclonal Antibodies Picture Figure 4. Interferon Picture Figure 5. Erythropoietin Picture Figure 6. Insulin Picture Figure 7. Vaccines Picture Figure 8. Other Picture Figure 9. Biologics and Biosimilars Sales Market Share by Application in 2018 Figure 10. Tumor Picture Figure 11. Diabetes Picture Figure 12. Cardiovascular Picture Figure 13. Hemophilia Picture Figure 14. Other Picture Figure 15. Global Biologics and Biosimilars Market Status and Outlook (2015-2025) (USD Million) Figure 16. United States Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025) Figure 17. Canada Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025) Figure 18. Mexico Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025) Figure 19. Germany Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025) Figure 20. France Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025) Figure 21. UK Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025) Figure 22. Russia Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025) Figure 23. Italy Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025) Figure 24. China Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025) Figure 25. Japan Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025) Figure 26. Korea Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025) Figure 27. India Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025) Figure 28. Southeast Asia Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025) Figure 29. Australia Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025) (USD Million) Figure 30. Brazil Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025) Figure 31. Egypt Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025) Figure 32. Saudi Arabia Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025) Figure 33. South Africa Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025) Figure 34. Turkey Biologics and Biosimilars Revenue (Value) and Growth Rate (2015-2025) Figure 35. Global Biologics and Biosimilars Sales Market Share by Manufacturer in 2019 Figure 36. Global Biologics and Biosimilars Revenue Market Share by Manufacturer in 2019 Figure 37. Top 3 Biologics and Biosimilars Manufacturer (Revenue) Market Share in 2019 Figure 38. Top 6 Biologics and Biosimilars Manufacturer (Revenue) Market Share in 2019 Figure 39. Key Manufacturer Market Share Trend Figure 40. Global Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units) Figure 41. Global Biologics and Biosimilars Revenue and Growth Rate (2015-2020) (USD Million) Figure 42. Global Biologics and Biosimilars Revenue Market Share by Regions (2015-2020) Figure 43. Global Biologics and Biosimilars Revenue Market Share by Regions in 2018 Figure 44. North America Biologics and Biosimilars Sales and Growth Rate (2015-2020) Figure 45. Europe Biologics and Biosimilars Sales and Growth Rate (2015-2020) Figure 46. Asia-Pacific Biologics and Biosimilars Sales and Growth Rate (2015-2020) Figure 47. South America Biologics and Biosimilars Sales and Growth Rate (2015-2020) Figure 48. Middle East & Africa Biologics and Biosimilars Sales and Growth Rate (2015-2020) Figure 49. North America Biologics and Biosimilars Revenue and Growth Rate (2015-2020) (USD Million) Figure 50. North America Biologics and Biosimilars Sales Market Share by Countries (2015-2020) Figure 51. North America Biologics and Biosimilars Sales Market Share by Countries in 2018 Figure 52. North America Biologics and Biosimilars Revenue Market Share by Countries (2015-2020) (USD Million) Figure 53. North America Biologics and Biosimilars Revenue Market Share by Countries in 2018 Figure 54. United States Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units) Figure 55. Canada Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units) Figure 56. Mexico Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units) Figure 57. Europe Biologics and Biosimilars Revenue and Growth Rate (2015-2020) (USD Million) Figure 58. Europe Biologics and Biosimilars Revenue Market Share by Countries (2015-2020) Figure 59. Europe Biologics and Biosimilars Revenue Market Share by Countries in 2019 Figure 60. Germany Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units) Figure 61. UK Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units) Figure 62. France Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units) Figure 63. Russia Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units) Figure 64. Italy Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units) Figure 65. Asia-Pacific Biologics and Biosimilars Revenue and Growth Rate (2015-2020) (USD Million) Figure 66. Asia-Pacific Biologics and Biosimilars Sales Market Share by Regions 2019 Figure 67. Asia-Pacific Biologics and Biosimilars Revenue Market Share by Regions 2019 Figure 68. China Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units) Figure 69. Japan Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units) Figure 70. Korea Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units) Figure 71. India Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units) Figure 72. Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units) Figure 73. South America Biologics and Biosimilars Revenue and Growth Rate (2015-2020) (USD Million) Figure 74. South America Biologics and Biosimilars Sales Market Share by Countries in 2019 Figure 75. South America Biologics and Biosimilars Revenue Market Share by Countries in 2019 Figure 76. Brazil Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units) Figure 77. Argentina Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units) Figure 78. Middle East and Africa Biologics and Biosimilars Revenue and Growth Rate (2015-2020) (USD Million) Figure 79. Middle East and Africa Biologics and Biosimilars Sales Market Share by Countries in 2019 Figure 80. Middle East and Africa Biologics and Biosimilars Revenue Market Share by Countries (2015-2020) Figure 81. Middle East and Africa Biologics and Biosimilars Revenue Market Share by Countries in 2019 Figure 82. Saudi Arabia Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units) Figure 83. Egypt Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units) Figure 84. Turkey Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units) Figure 85. South Africa Biologics and Biosimilars Sales and Growth Rate (2015-2020) (K Units) Figure 86. Global Biologics and Biosimilars Sales and Growth Rate (2021-2025) (K Units) Figure 87. Global Biologics and Biosimilars Revenue and Growth Rate (2021-2025) (USD Million) Figure 88. North America Sales Biologics and Biosimilars Market Forecast (2021-2025) (K Units) Figure 89. Europe Sales Biologics and Biosimilars Market Forecast (2021-2025) (K Units) Figure 90. Asia-Pacific Sales Biologics and Biosimilars Market Forecast (2021-2025) (K Units) Figure 91. South America Sales Biologics and Biosimilars Market Forecast (2021-2025) (K Units) Figure 92. Middle East & Africa Sales Biologics and Biosimilars Market Forecast (2021-2025) (K Units) Figure 93. Sales Channel: Direct Channel vs Indirect Channel

Roche Eli Lilly Sanofi-Aventis Amgen Novo Nordisk AbbVie Merck Pfizer Johnson & Johnson Novartis Gelgen Ganlee 3sbio Innovent Biotech Changchun High Tech Dong Bao CP Guojian